Coincidence of multiple endocrine neoplasia type 2A with acromegaly

American Journal of the Medical Sciences

Volumn 340, Issue 4, 2010, Pages 329-331

  Saito, Tsunenori ^a,b   Miura, Daishu ^b,c   Taguchi, Manabu ^b,c   Takeshita, Akira ^b,c   Miyakawa, Megumi ^b,c   Takeuchi, Yasuhiro ^b  

^a NIPPON MEDICAL SCHOOL HOSPITAL   (Japan)

^b TORANOMON HOSPITAL   (Japan)

^c Okinaka Memorial Institute for Medical Research   (Japan)

Author keywords

Acromegaly; Medullary thyroid carcinoma; MEN1 mutation; Multiple endocrine neoplasia type 2A; RET mutation

Indexed keywords

PROTEIN RET;

ACROMEGALY; ADULT; ARTICLE; CASE REPORT; GENE IDENTIFICATION; GENE INTERACTION; GENE MUTATION; GERM LINE; HUMAN; MALE; MULTIPLE ENDOCRINE NEOPLASIA; PATIENT REFERRAL; SIPPLE SYNDROME; THYROID MEDULLARY CARCINOMA;

EID: 77957985118     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3181e73fba     Document Type: Article

References (21)

1. Schimke RN. Genetic aspects of multiple endocrine neoplasia. Annu Rev Med 1984;35:25-31.
2. Eng C, Clayton D, Schuffenecker I, et al. The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. JAMA 1996;276:1575-1579
3. Melmed S. Acromegaly. N Engl J Med 1990;322:966-977
4. Brandi ML, Marx SJ, Aurbach GD, et al. Familial multiple endocrine neoplasia type 1: a new look at pathophysiology. Endocr Rev 1987;8:391-405.
5. Larsson C, Skogseid B, O'berg K, et al. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 1988;332:85-87
6. Tita P, Ambrosia MR, Scollo C, et al. High prevalence of differentiated thyroid carcinoma in acromegaly. Clin Endocrinol 2005;63: 161-167
7. Brazilay J, Heatly GJ, Cushing GW. Benign and malignant tumors in patients with acromegaly. Arch Intern Med 1991;151:1629-1632
8. Popovic V, Damjanovic S, Micic D, et al. Increased incidence of neoplasia in patients with pituitary adenomas. The pituitary study group. Clin Endocrinol 1998;47:441-445
9. Siegel G, Tomer Y. Is there an association between acromegaly and thyroid carcinoma? a critical review of the literature. Endocr Res 2005;31:51-58
10. Kitagawa D, Miura D, Suzuki N. A case of sporadic medullary carcinoma with a pituitary adenoma and a parathyroid adenoma. Endocr Surg 2006;23:110-114 [In Japanese with English abstract.]
11. Brauer VFH, Scholz GH, Neumann S, et al. RET germline mutation in codon 791 in a family representing 3 generations from age 5 to age 70 years: should thyroidectomy be performed? Endocr Pract 2004;10: 5-9.
12. Frank-Raue K, Rondot S, Hoeppner W, et al. Coincidence of multiple endocrine neoplasia types 1 and 2: mutations in the RET protooncogene and MEN1 tumor suppressor gene in a family presenting with recurrent primary hyperparathyroidism. J Clin Endocrinol Metab 2005;90:4063-4067
13. Mulligan LM, Eng C, Healey CS, et al. Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC. Nat Genet 1994;6:70-74
14. Xue F, Yu H, Maurer LH, et al. Germline RET mutations in MEN 2A and FMTC and their detection by simple DNA diagnostic tests. Hum Mol Genet 1994;3:635-638
15. Schuffenecker I, Virally-Monod M, Brohet R, et al. Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene. J Clin Endocrinol Metab 1998;83:487-491
16. Egawa S, Futami H, Takasaki K, et al. Genotype-phenotype correlation of patients with multiple endocrine neoplasia type 2 in Japan. Jpn J Clin Oncol 1998;28:590-596 (Pubitemid 128525797)
17. Neumann HPH, Bausch B, McWhinney SR, et al. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 2002;346: 1459-1466
18. Fitze G, Schierz M, Bredow J, et al. Various penetrance of familial medullary thyroid carcinoma in patients with RET protooncogene 790/791 germline mutations. Ann Surg 2002;236:570-575
19. Piolat C, Dyon JF, Sturm N, et al. Very early prophylactic thyroid surgery for infants with a mutation of the RET proto-oncogene at codon 634: evaluation of the implementation of international guidelines for MEN type 2 in a single centre. Clin Endocrinol 2006;65:118-124
20. Urbano AG, Suarez-Penaranda JM, Dieguez C, et al. GDNF and RET gene expression in anterior pituitary-cell types. Endocrinology 2000;141:1893-1896
21. Japon MA, Urbano AG, Saez C, et al. Glial-derived neurotropic factor and RET gene expression in normal human anterior pituitary cell types and pituitary tumors. J Clin Endocrinol Metab 2002;87:1879-1884